Global Real World Evidence Solutions Market Report By Component (Claims Data, Clinical Settings Data, Patient-Powered Data, Pharmacy Data, Services), By Therapeutic Area (Oncology, Immunology, Neurology, cardiovascular Disease, Other), By End User (Healthcare Payers, Healthcare Providers, Pharmaceutical & Medical Device Companies, Other) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11212359
May 2020
Report Formats:

The global demand for Real World Evidence Solutions Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Real-world evidence is a concept of collecting observational data from real-world outside the context of a randomised controlled trial. The data is generated during routine clinical practice to assess the patient's outcome. The record is stored in electronic health records, mobile devices, billing activities databases, etc. The RWE play a critical role in health and clinical studies, provides a solution to the problem, understands the patient pathway to deliver the appropriate care and also analyse effects of drugs during a timespan.
 
Market Dynamics
 
Real-World Evidence plays an essential role in health care decisions to monitor postmarket safety and adverse events. Healthcare product developers are using RWE to support observational studies and clinical trial designed to generate new treatment approaches. Growing healthcare and clinical trials are driving the growth of the market. Pharmaceutical industries are investing in the market to boost patients experience by providing observational studies, patient-centred research activities through social media and selectronic medical devices. Despite being a major contributor to clinical research, RWE faces challenges such as availability of data, different EMR system, concerns about quality and precision and governance issues. 
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Real World Evidence Solutions.
 
Market Segmentation
 
The entire Real World Evidence Solutions market has been sub-categorized into component, therepeutic area, end user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Component

  • Claims Data
  • Clinical Settings Data
  • Patient-Powered Data
  • Pharmacy Data
  • Services
 
By Therapeutic Area
  • Oncology
  • Immunology
  • Neurology
  • Cardiovascular Disease
  • Other
 
By End User
  • Healthcare Payers
  • Healthcare Providers
  • Pharmaceutical & Medical Device Companies
  • Other
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for Real World Evidence Solutions market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Real World Evidence Solutions Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Real World Evidence Solutions market include Iqvia, IBM, Oracle, Parexel, Optum. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Real World Evidence Solutions Market
       2.2. Global Real World Evidence Solutions Market Snapshot
 
3 . REAL WORLD EVIDENCE SOLUTIONS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Real World Evidence Solutions Market
       3.3. Market Restraints of Real World Evidence Solutions Market
       3.4. Opportunities of Real World Evidence Solutions Market
       3.5. Trends of Real World Evidence Solutions Market
       3.6. Porter’s Five Force Analysis of Real World Evidence Solutions Market
       3.7. Real World Evidence Solutions Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Component
           3.7.2 Market Attractive Analysis by Therapeutic Area
           3.7.3 Market Attractive Analysis by End User
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Real World Evidence Solutions Value Chain Analysis
       4.2. Real World Evidence Solutions Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Real World Evidence Solutions Raw Material Manufactures List
           4.2.3. Price Trend of Real World Evidence Solutions Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Real World Evidence Solutions Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Real World Evidence Solutions Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Real World Evidence Solutions Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Real World Evidence Solutions Market
 
6 . GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY COMPONENT
       6.1 Overview by Component
       6.2 Global Real World Evidence Solutions Market Analysis by Component
       6.3 Market Analysis of Claims Data by Regions
       6.4 Market Analysis of Clinical Settings Data by Regions
       6.6 Market Analysis of Patient-Powered Data by Regions
       6.5 Market Analysis of Pharmacy Data by Regions
       6.7 Market Analysis of Services by Regions
 
7 . GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY THERAPEUTIC AREA
       7.1 Overview by Therapeutic Area
       7.2 Global Real World Evidence Solutions Market Analysis by Therapeutic Area
       7.3 Market Analysis of Oncology by Regions
       7.4 Market Analysis of Immunology by Regions
       7.5 Market Analysis of Neurology by Regions
       7.6 Market Analysis of Cardiovascular Disease by Regions
       7.7 Market Analysis of Other by Regions
 
8 . GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY END USER
       8.1 Overview by End User
       8.2 Global Real World Evidence Solutions Market Analysis by End User
       8.3 Market Analysis of Healthcare Payers by Regions
       8.4 Market Analysis of Healthcare Providers by Regions
       8.5 Market Analysis of Pharmaceutical & Medical Device Companies by Regions
       8.6 Market Analysis of Other by Regions
 
9 . GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Real World Evidence Solutions Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Real World Evidence Solutions Market Estimate by Market Segment
           9.4.3. Europe Real World Evidence Solutions Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Real World Evidence Solutions Market Estimate by Market Segment
           9.5.3. Asia Pacific Real World Evidence Solutions Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Real World Evidence Solutions Market Estimate by Market Segment
           9.6.3. Latin America Real World Evidence Solutions Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Real World Evidence Solutions Market Estimate by Market Segment
           9.7.3. Middle East & Africa Real World Evidence Solutions Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa
 
10 . COMPETITIVE LANDSCAPE OF THE REAL WORLD EVIDENCE SOLUTIONS COMPANIES
       10.1. Real World Evidence Solutions Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF REAL WORLD EVIDENCE SOLUTIONS INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Iqvia
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. IBM
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Oracle
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Parexel
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Optum
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Real World Evidence Solutions Market Snapshot
  • Drivers of The Global Real World Evidence Solutions Market Impact Analysis
  • Restraints of The Global Real World Evidence Solutions Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Real World Evidence Solutions Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Real World Evidence Solutions Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Real World Evidence Solutions Market
  • Global Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Claims Data by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Clinical Settings Data by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Patient-Powered Data by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Pharmacy Data by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Services by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis by Therapeutic Area (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Oncology by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Immunology by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Neurology by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Cardiovascular Disease by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Other by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis by End User (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Healthcare Payers by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Healthcare Providers by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Pharmaceutical & Medical Device Companies by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Other by Geography (USD MN)
  • Global Real World Evidence Solutions Market by Geography (USD MN)
  • North America Real World Evidence Solutions Market Analysis by Component (USD MN)
  • North America Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • North America Real World Evidence Solutions Market Estimate by End User (USD MN)
  • North America Real World Evidence Solutions Market Estimate by Country (USD MN)
  • United State Real World Evidence Solutions Market Analysis by Component (USD MN)
  • United State Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • United State Real World Evidence Solutions Market Analysis by End User (USD MN)
  • Rest of North America Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Rest of North America Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Rest of North America Real World Evidence Solutions Market Estimate by End User(USD MN)
  • Europe Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Europe Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Europe Real World Evidence Solutions Market Estimate by End User (USD MN)
  • United Kingdom Real World Evidence Solutions Market Analysis by Component (USD MN)
  • United Kingdom Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • United Kingdom Real World Evidence Solutions Market Estimate by End User (USD MN)
  • France Real World Evidence Solutions Market Analysis by Component (USD MN)
  • France Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • France Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Germany Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Germany Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Germany Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Rest of Europe Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Rest of Europe Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Rest of Europe Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Asia Pacific Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Asia Pacific Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Asia Pacific Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Asia Pacific Real World Evidence Solutions Market Estimate by Country (USD MN)
  • China Real World Evidence Solutions Market Analysis by Component (USD MN)
  • China Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • China Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Japan Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Japan Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Japan Real World Evidence Solutions Market Estimate by End User (USD MN)
  • India Real World Evidence Solutions Market Analysis by Component (USD MN)
  • India Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • India Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Rest of Asia Pacific Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Rest of Asia Pacific Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Rest of Asia Pacific Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Latin America Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Latin America Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Latin America Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Latin America Real World Evidence Solutions Market Estimate by Country (USD MN)
  • Brazil Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Brazil Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Brazil Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Rest of Latin America Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Rest of Latin America Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Rest of Latin America Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Middle East & Africa Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Middle East & Africa Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Middle East & Africa Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Middle East & Africa Real World Evidence Solutions Market Estimate by Country (USD MN)
  • Middle East Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Middle East Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Middle East Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Africa Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Africa Real World Evidence Solutions Market Estimate by Therapeutic Area (USD MN)
  • Africa Real World Evidence Solutions Market Estimate by End User (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Real World Evidence Solutions Report
  • Market Research Process
  • Market Research Methodology
  • Global Real World Evidence Solutions Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Component
  • Market Attractiveness Analysis by Therapeutic Area
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Real World Evidence Solutions Market Analysis by Component (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Claims Data by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Clinical Settings Data by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Patient-Powered Data by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Pharmacy Data by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Services by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis by Therapeutic Area (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Oncology by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Immunology by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Neurology by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Cardiovascular Disease by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Other by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis by End User (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Healthcare Payers by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Healthcare Providers by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Pharmaceutical & Medical Device Companies by Geography (USD MN)
  • Global Real World Evidence Solutions Market Analysis in Other by Geography (USD MN)
  • Latin America Real World Evidence Solutions Market by Revenue
  • Middle East & Africa Real World Evidence Solutions Market by Revenue
  • Recent Development in Real World Evidence Solutions Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials